Pulsenmore Ltd. is an Israeli digital health company specializing in home-use ultrasound and telehealth technology for physician-supervised prenatal monitoring. Founded in 2014 and headquartered in Ramat Gan, it develops proprietary portable ultrasound devices, such as the Pulsenmore ES, that enable pregnant women to perform self-scans at home, with secure cloud-based image transmission for remote clinical review by healthcare providers. This platform enhances access to prenatal care, improves continuity, reduces clinic visits, and boosts patient satisfaction, particularly in underserved areas. Pulsenmore has received FDA authorization for its home prenatal ultrasound system—the first of its kind—along with regulatory approvals in Europe, the UK, Switzerland, Australia, Brazil, and Israel. Operating at the intersection of telehealth and femtech, the company collaborates with major partners like GE HealthCare and Clalit Health Services, and holds over 70 patents. With more than 120,000 self-scans performed across Europe, Australia, Brazil, and Israel, Pulsenmore plays a pivotal role in transforming maternal health by making high-quality, patient-centric prenatal care accessible outside traditional clinical settings.